Novel NMR-based method could facilitate safer API manufacturing
The innovative approach for detecting nitrosamine impurities in APIs addresses limitations of traditional mass-based techniques, research says.
List view / Grid view
The innovative approach for detecting nitrosamine impurities in APIs addresses limitations of traditional mass-based techniques, research says.
Changes proposed in the EU body’s regulatory framework aim to create a competitive and sustainable European bioeconomy.
The modern Industrial Strategy is informing the UK government’s decisions in the Budget.
Swiss pharma company to trim production of oral medicines and packaging in Stein, while boosting productivity in Schweizerhalle.
The move is part of biopharma's $50 billion pledge to US medicines manufacturing and R&D.
The companies’ partnership covers messenger RNA design and production services.
R&D projects supported by the Centre for Process Innovation (CPI) aim to shape a sustainable, resilient and competitive future for pharma manufacturing.
The expansion places the pharma company’s full manufacturing loop in the US under one roof.
The pharmaceutical laboratory meeting adds sessions on AI in labs, and quality in biologics, mRNA and analytics.
As well as the new safety warnings for the Duchenne muscular dystrophy gene therapy, the biopharma company also faced a new, more restrictive licence for the treatment.
By utilising patient-derived instead of donor-derived platelets, the method could offer a safer approach to platelet transfusions.
He joins from contract development and manufacturing organisation Porton Pharma Solutions.
The German pharma company’s agreement for its South Korea sites is the latest green initiative to be unveiled by the industry.
California site adds to the Swiss pharma company’s operations in Florida and Texas.
Supply crisis of antibiotics in Europe adds burden to regional efforts to overcome antimicrobial resistance (AMR), says a new report.